Instrument details

Instrument Title

Self-efficacy for Disclosing HIV Status to a Sex Partner

View PDF - Self-efficacy for Disclosing HIV Status to a Sex Partner_Mizuno.pdf

Source Article

Mizuno, Y., Purcell, D. W., Latka, M. H., Metsch, L. R., Gomez, C. A., & Latkin, C. A. (2007). Beliefs that condoms reduce sexual Pleasure—Gender differences in correlates among heterosexual HIV-positive injection drug users (IDUs). Journal of Urban Health, 84(4), 523-536.

Response Options

1. Absolutely not
2. Pretty sure I cannot
3. Not sure
4. Pretty sure I can
5. Absolutely sure I can
6. Refuse to answer

Survey Items

1. I can tell a new sex partner my HIV status before having sex even if I am really attracted to them.
2. I can tell a sex partner my HIV status before having sex even if they might know some of my friends.
3. I can tell a sex partner my HIV status before having sex even when I’m depressed or really upset.
4. I can tell a sex partner my HIV status before having sex even if my partner did not know I was HIV positive the first time we had sex.
5. I can tell a new partner my HIV status before having sex even if I’m worried that they wouldn’t have sex with me if they knew.
6. I can tell a sex partner my HIV status before having sex even if they have not told me their HIV status.

Internal Reliability

Reliability information was not available.

Validity

Validity information was not available.

Google Scholar

View article on Google Scholar

Terms Of Use

Individuals may use this information for research or educational purposes only and may not use this information for commercial purposes. When using this instrument, please cite:

Mizuno, Y., Purcell, D. W., Latka, M. H., Metsch, L. R., Gomez, C. A., & Latkin, C. A. (2007). Beliefs that condoms reduce sexual Pleasure—Gender differences in correlates among heterosexual HIV-positive injection drug users (IDUs). Journal of Urban Health, 84(4), 523-536.

When presenting results using any survey information you obtained from the SABI, please acknowledge the University of North Carolina at Chapel Hill Center for AIDS Research (CFAR), an NIH funded program P30 AI50410.